This firm conducts business under Healthcare sector and is part of Biotechnology industry. The company holds a Beta of -0.0775, which implies not very significant fluctuations relative to the market. Let's try to break down what Passage's beta means in this case. As returns on the market increase, returns on owning Passage Bio are expected to decrease at a much lower rate. During the bear market, Passage Bio is likely to outperform the market. Even though it is essential to pay attention to Passage Bio current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Our philosophy towards forecasting any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Passage Bio exposes twenty-seven different technical indicators, which can help you to evaluate its performance. Passage Bio has an expected return of -1.05%. Please be advised to check Passage Bio expected short fall, and the relationship between the value at risk and daily balance of power to decide if Passage Bio performance from the past will be repeated at some point in the near future.
